Waverly Advisors LLC Boosts Stake in CVS Health Corporation $CVS

Waverly Advisors LLC boosted its holdings in shares of CVS Health Corporation (NYSE:CVS) by 7.9% during the 2nd quarter, according to its most recent 13F filing with the SEC. The fund owned 90,642 shares of the pharmacy operator’s stock after purchasing an additional 6,672 shares during the period. Waverly Advisors LLC’s holdings in CVS Health were worth $9,377,000 as of its most recent filing with the SEC.

Several other large investors have also modified their holdings of CVS. Paragon Capital Management Ltd purchased a new stake in CVS Health in the 2nd quarter valued at approximately $263,000. Empirical Finance LLC increased its position in CVS Health by 2.9% during the second quarter. Empirical Finance LLC now owns 53,764 shares of the pharmacy operator’s stock worth $5,562,000 after buying an additional 1,510 shares in the last quarter. Nykredit A S purchased a new stake in shares of CVS Health in the second quarter valued at $209,813,000. Parkside Financial Bank & Trust increased its position in CVS Health by 7.5% during the 2nd quarter. Parkside Financial Bank & Trust now owns 5,211 shares of the pharmacy operator’s stock worth $539,000 after purchasing an additional 365 shares in the last quarter. Finally, Range Advisory LLC acquired a new stake in shares of CVS Health during the 2nd quarter worth about $544,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Stock Down 0.7%

Shares of NYSE CVS opened at $95.43 on Thursday. The stock has a market capitalization of $122.05 billion, a PE ratio of 25.25, a P/E/G ratio of 0.94 and a beta of 0.59. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.74. The firm has a fifty day moving average of $100.31 and a 200-day moving average of $90.61. CVS Health Corporation has a 52-week low of $69.51 and a 52-week high of $110.68.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, beating analysts’ consensus estimates of $1.87 by $0.71. The firm had revenue of $106.10 billion for the quarter, compared to analysts’ expectations of $100.03 billion. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The firm’s revenue for the quarter was up 7.3% compared to the same quarter last year. During the same quarter last year, the firm earned $1.81 earnings per share. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, analysts anticipate that CVS Health Corporation will post 8.02 EPS for the current year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, August 3rd. Investors of record on Thursday, July 23rd were given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 2.8%. The ex-dividend date of this dividend was Thursday, July 23rd. CVS Health’s dividend payout ratio is 70.37%.

CVS Health News Summary

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Recent coverage highlighted CVS Health’s improving business performance and financial results. The company’s latest reported quarter included adjusted earnings of $2.58 per share, above the $1.87 analyst consensus, while revenue increased 7.3% year over year. CVS has issued fiscal 2026 earnings guidance of $7.90–$8.10 per share. Wall Street Loves CVS Health Stock Right Now. Should You?
• Positive Sentiment: Zacks identified CVS as a strong momentum stock, while increased investor attention could support near-term trading interest. These assessments are based largely on quantitative and sentiment factors rather than a new company announcement. Here’s Why CVS Health Is a Strong Momentum Stock
• Neutral Sentiment: CVS marked the 20th anniversary of its free community health-screening program. A company-commissioned survey found that nearly one in four U.S. adults has delayed contacting a health professional because of access, cost or availability barriers, while one-third were unaware of community screening programs. The initiative may support CVS’s community-health reputation but is unlikely to materially affect near-term earnings. CVS Health Community Health Screening Program
• Negative Sentiment: CVS flagged elevated medical expenses, raising concerns about profit margins and earnings visibility across its managed-care operations. The warning pressured the broader managed-care group and is the clearest near-term reason for weakness in CVS stock. CVS Health Flags Elevated Medical Expenses

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on CVS shares. Barclays boosted their price objective on shares of CVS Health from $106.00 to $108.00 and gave the company an “overweight” rating in a research report on Thursday, August 6th. Morgan Stanley boosted their price target on CVS Health from $106.00 to $111.00 and gave the company an “overweight” rating in a report on Thursday, June 4th. Robert W. Baird set a $107.00 price objective on CVS Health in a research report on Thursday, August 6th. Wall Street Zen upgraded CVS Health from a “buy” rating to a “strong-buy” rating in a research report on Saturday, August 8th. Finally, Piper Sandler set a $112.00 price target on CVS Health in a research note on Wednesday. Twenty-two equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $107.24.

CVS Health Profile

CVS Health Corporation is an American health care company headquartered in Woonsocket, Rhode Island. Founded in 1963 as Consumer Value Stores, the company has expanded from a chain of retail pharmacies into an integrated health care organization serving consumers, employers, health plans, government programs and health care providers.

CVS Health operates through several major businesses. Its Health Care Benefits segment, anchored by Aetna, provides health insurance products and related services for employers, individuals, Medicare and Medicaid members.